Abstract:ABSTRACT Antibiotic resistance poses a significant public health threat worldwide. The rise in antibiotic resistance and the sharp decline in effective antibiotics necessitate the development of innovative antibacterial agents. Based on the central symmetric structure of glycine–serine–glycine, combined with tryptophan and arginine, we designed a range of antimicrobial peptides (AMPs) that exhibited broad-spectrum antibacterial activity. Notably, AMP W 5 demonstrated a rapid and effective sterilization against methicillin-resistant Staphylococcus aureus (MRSA), displaying both a minimum inhibitory concentration and a minimum bactericidal concentration of 8 μM. Mechanistic studies revealed that AMP W 5 killed bacterial cells by disrupting the cytoplasmic membrane integrity, triggering leakage of cell contents. AMP W 5 also exhibited excellent biocompatibility in both in vitro and in vivo safety evaluations. AMP W 5 treatment significantly reduced skin bacterial load in our murine skin infection model. In conclusion, we designed a novel centrosymmetric AMP representing a promising medical alternative to conventional antibiotics for treating MRSA infections. IMPORTANCE Increasing antibiotic resistance and the paucity of effective antibiotics necessitate innovative antibacterial agents. Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen causing bacterial infections with high incidence and mortality rates, showing increasing resistance to clinical drugs. Antimicrobial peptides (AMPs) exhibit significant potential as alternatives to traditional antibiotics. This study designed a novel series of AMPs, characterized by a glycine–serine–glycine-centered symmetrical structure, and our results indicated that AMP W5 exhibited a rapid and effective bactericidal effect against MRSA. AMP W5 also demonstrated excellent biocompatibility and a bactericidal mechanism that disrupted membrane integrity, leading to leakage of cellular contents. The notable reduction in skin bacterial load observed in mouse models reinforced the clinical applicability of AMP W5. This study provides a promising solution for addressing the increasing threat of antibiotic-resistant bacteria and heralds new prospects for clinical applications.

A New Gramicidin S Analogue with Potent Antibacterial Activity and Negligible Hemolytic Toxicity

Recent advances in the exploration of therapeutic analogues of Gramicidin S, an old but still potent antimicrobial peptide.

Development of Therapeutic Gramicidin S Analogues Bearing Plastic β,γ-Diamino Acids.

Development of Therapeutic Gramicidin S Analogues Bearing Plastic Β,γ‐diamino Acids

Optimization Of Globomycin Analogs As Novel Gram-Negative Antibiotics

An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria

Deformylated Gramicidin A and Its Derivatives Showing High Antimicrobial Activity and Low Hemolytic Toxicity

Gramicidin‐S‐Inspired Cyclopeptidomimetics As Potent Membrane‐Active Bactericidal Agents with Therapeutic Potential

Antimicrobial activity of novel symmetrical antimicrobial peptides centered on a hydrophilic motif against resistant clinical isolates: in vitro and in vivo analyses

Two Optimized Antimicrobial Peptides with Therapeutic Potential for Clinical Antibiotic-Resistant Staphylococcus Aureus.

Antibacterial and Antibiofilm Activities of Novel Cyclic Peptides against Methicillin-Resistant <i>Staphylococcus aureus</i>

Novel gramicidin-derived 𝛽-helical antimicrobial peptides

Discovery of Cationic Nonribosomal Peptides As Gram-negative Antibiotics Through Global Genome Mining

Polymyxin B-inspired Non-Hemolytic Tyrocidine A Analogues with Significantly Enhanced Activity Against Gram-Negative Bacteria: How Cationicity Impacts Cell Specificity and Antibacterial Mechanism

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

The Antimicrobial Peptides and Their Potential Clinical Applications.

High Potency and Broad-Spectrum Antimicrobial Peptides Synthesized Via Ring-Opening Polymerization of Alpha-Aminoacid-n-carboxyanhydrides.

Triazole-Bridged Peptides with Enhanced Antimicrobial Activity and Potency against Pathogenic Bacteria

In Silico and In Vitro Analyses Reveal Promising Antimicrobial Peptides from Myxobacteria